Alkermes plc (ALKS)
NASDAQ: ALKS · Real-Time Price · USD
30.92
-0.35 (-1.12%)
May 13, 2025, 1:30 PM - Market open
Revenue by Product
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2017 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2017 - 2019 |
| Medicines - Product | 1.08B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Medicines - Product Growth | 17.78% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Manufacturing and Royalty | 474.10M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Manufacturing and Royalty Growth | -36.23% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Research and Development | 3.00K |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Research and Development Growth | -84.21% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| License | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| License Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Revenue by Geography
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2017 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2017 - 2019 |
| United States | 1.41B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| United States Growth | -5.48% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Rest of World | 146.18M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Rest of World Growth | -14.16% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Ireland | 1.29M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Ireland Growth | 9.75% |
Log In |
Log In |
Log In |
Log In | Upgrade
|